UBS Group’s Nano Labs NA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21K Buy
11,360
+63
+0.6% +$145 ﹤0.01% 8139
2026
Q1
$33.4K Sell
11,297
-50,167
-82% -$160K ﹤0.01% 7619
2025
Q4
$194K Buy
61,464
+48,906
+389% +$210K ﹤0.01% 6595
2025
Q3
$67.8K Buy
12,558
+12,094
+2,606% +$72K ﹤0.01% 7354
2025
Q2
$4.31K Sell
464
-5,333
-92% -$32.4K ﹤0.01% 9282
2025
Q1
$26.1K Buy
5,797
+4,144
+251% +$26.6K ﹤0.01% 8043
2024
Q4
$14.8K Buy
1,653
+1,250
+310% +$9.24K ﹤0.01% 8072
2024
Q3
$3.1K Sell
403
-10,213
-96% -$37K ﹤0.01% 8314
2024
Q2
$47.2K Buy
10,616
+10,613
+353,767% +$70K ﹤0.01% 6732
2024
Q1
$55 Sell
3
-49
-94% -$812 ﹤0.01% 8916
2023
Q4
$934 Buy
52
+36
+225% +$546 ﹤0.01% 8470
2023
Q3
$197 Sell
16
-12
-43% -$162 ﹤0.01% 8716
2023
Q2
$552 Sell
28
-698
-96% -$11.1K ﹤0.01% 8182
2023
Q1
$7.55K Buy
+726
New +$9.06K ﹤0.01% 7797
2022
Q4
Sell
-429
Closed -$7K 10996
2022
Q3
$7K Buy
+429
New +$25.9K ﹤0.01% 8887

Other funds holding NA

UBS Group's NA Position: Q2 2026 in Review

UBS Group increased its Nano Labs (NA) stake by 0.56% in Q2 2026, buying an estimated $145 and bringing the position to 11,360 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #8139.

UBS Group first reported a position in NA in Q3 2022 and has held it in 15 quarters since. The position peaked at $194K in Q4 2025. 6 funds tracked by Wall St. Rank hold NA as of Q2 2026.

  • UBS Group held 11,360 shares of Nano Labs worth $21K as of Q2 2026.
  • UBS Group bought 63 Nano Labs shares in Q2 2026, an estimated $145.
  • Nano Labs made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8139 holding.
  • UBS Group first reported a position in Nano Labs in Q3 2022 and has held it in 15 quarters since.
  • UBS Group's Nano Labs position peaked at $194K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Nano Labs as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.